Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4676
Innovator US Equity Buffer ETF November
BNOV
$190M
| $19.6K | ﹤0.01% |
400
-1,173
| -75% | -$57K |
2026 Q2
1 quarter
|
|
4677
Eupraxia Pharmaceuticals
EPRX
$455M
| $19.4K | ﹤0.01% |
+2,136
| New | +$15.2K |
2026 Q3
0 quarters
|
|
4678
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.81B
| $19.4K | ﹤0.01% |
805
| – | – |
2026 Q1
2 quarters
|
|
4679
NeuroOne Medical Technologies
NMTC
$8M
| $19.3K | ﹤0.01% |
18,757
+18,681
| +24,580% | +$35.1K |
2026 Q2
1 quarter
|
|
4680
Oppenheimer Holdings
OPY
$972M
| $18.9K | ﹤0.01% |
160
-17
| -10% | -$1.96K |
2025 Q4
3 quarters
|
|
4681
Werewolf Therapeutics
HOWL
$49.1M
| $18.8K | ﹤0.01% |
20,390
+7,155
| +54% | +$4.54K |
2024 Q1
10 quarters
|
|
4682
Armata Pharmaceuticals
ARMP
$131M
| $18.8K | ﹤0.01% |
5,122
+2,138
| +72% | +$10.2K |
2026 Q1
2 quarters
|
|
4683
Ternium
TX
$9.7B
| $18.8K | ﹤0.01% |
346
-29
| -8% | -$1.5K |
2017 Q2
37 quarters
|
|
4684
XPLR Infrastructure LP
XIFR
$690M
| $18.7K | ﹤0.01% |
1,787
+1,460
| +446% | +$17K |
2017 Q3
36 quarters
|
|
4685
Corporacion America
CAAP
$4.01B
| $18.7K | ﹤0.01% |
+735
| New | +$18.1K |
2026 Q3
0 quarters
|
|
4686
Adecoagro
AGRO
$1.3B
| $18.6K | ﹤0.01% |
1,831
-4,357
| -70% | -$45.8K |
2025 Q2
5 quarters
|
|
4687
Intellicheck
IDN
$41.3M
| $18.5K | ﹤0.01% |
8,041
+3,546
| +79% | +$11.5K |
2026 Q1
2 quarters
|
|
4688
Silver Bow Mining Corp
SBMT
$163M
| $18.4K | ﹤0.01% |
2,100
+646
| +44% | +$4.87K |
2026 Q2
1 quarter
|
|
4689
OptimumBank Holdings
OPHC
$112M
| $18.3K | ﹤0.01% |
2,099
+2,029
| +2,899% | +$16.5K |
2026 Q2
1 quarter
|
|
4690
AllianzIM U.S. Equity Buffer15 Uncapped Aug ETF
AUGU
$39.8M
| $18.1K | ﹤0.01% |
563
| – | – |
2026 Q1
2 quarters
|
|
4691
Finance of America Companies
FOA
$119M
| $18K | ﹤0.01% |
1,426
+993
| +229% | +$20.2K |
2024 Q4
7 quarters
|
|
4692
AllianzIM U.S. Equity Buffer10 Dec ETF
DECT
$36.2M
| $17.9K | ﹤0.01% |
444
| – | – |
2026 Q2
1 quarter
|
|
|
NVA
4693
Nova Minerals Corp
NVA
$165M
| $17.9K | ﹤0.01% |
+3,300
| New | +$17.4K |
2026 Q3
0 quarters
|
|
4694
Brainsway
BWAY
$449M
| $17.8K | ﹤0.01% |
1,352
-83
| -6% | -$1.23K |
2026 Q1
2 quarters
|
|
4695
Katapult Holdings
KPLT
$938M
| $17.8K | ﹤0.01% |
4,073
+4,049
| +16,871% | +$28.3K |
2026 Q2
1 quarter
|
|
4696
Comscore
SCOR
$51.1M
| $16.8K | ﹤0.01% |
+3,583
| New | +$21.9K |
2026 Q3
0 quarters
|
|
4697
TOYO Co
TOYO
$229M
| $16.8K | ﹤0.01% |
3,858
+2,717
| +238% | +$13.7K |
2026 Q2
1 quarter
|
|
4698
Quantinuum Inc
QNT
$1.48B
| $16.7K | ﹤0.01% |
+347
| New | +$19.7K |
2026 Q3
0 quarters
|
|
4699
Merlin Inc
MRLN
$87.9M
| $16.3K | ﹤0.01% |
8,674
-1,709
| -16% | -$5.86K |
2026 Q2
1 quarter
|
|
4700
ORIX
IX
$37.3B
| $16.2K | ﹤0.01% |
+430
| New | +$17K |
2026 Q3
0 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.